Monday, 19 October 2015
FDA Scrutiny Raises Questions About Theranos’ ‘Breakthrough’ Blood Tests
In the wake of a Food and Drug Administration warning letter to the testing startup, news outlets report on Theranos' hyped technology that the company says can screen for diseases with only a few drops of blood from a finger prick.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment